![]() |
![]() | |||||||||||
![]() |
|
Faculty Reseach Interests
MAVIS AGBANDJE-MCKENNA (392-5694) - My research interests center around structure function
relationships, with the belief that knowledge of structure is essential to understanding the
function of biological macromolecules and the numerous array of intricate macromolecular
interactions that govern biological processes. The main body of my research is aimed at
using a multi-disciplinary approach (structural biology - namely X-ray crystallography
and cryo-electron microscopy - in combination with expertise in molecular biology,
molecular genetics, biochemistry, histopathology and spectroscopy in collaborating
laboratories) to examine events that occur during viral infection. The goal is to
elucidate essential structural information that can be applied to the development
of treatments of viral diseases that afflict animals and plants, in the form of
viral vaccines, foreign antigen delivery vehicles and gene therapy systems.
JOHN P. ARIS - Cellular Aging Mechanisms. Our laboratory is interested in the cellular basis
for aging. There are a number of mechanisms at the cellular level that contribute to the aging process,
including, but not limited to: (1) genomic instability; (2) reactive oxygen species (ROS) damage; and
(3) impaired DNA repair pathways. Genomic instability includes loss and rearrangement of genetic information
in either dividing or non-dividing cells. For example, shortening of telomeres (loss of telomeric repeat
sequences) at chromosome ends in dividing cells leads to replicative senescence (failure to divide).
In yeast, recombination within the repetitive rDNA sequence give rise to extrachromosomal circular rDNAs
that are linked to the aging process. We use yeast as an experimental system because of the ease of using
various approaches in biochemistry, cell biology, genetics, and molecular biology. Our goal is to pursue
mechanisms that regulate replicative lifespan in yeast cells and extend our studies to other cells types
in order to better understand general mechanisms that influence aging at the cellular level.
LINDA BLOOM (392-8708) - Our general research interests are in the dynamic protein-protein and
protein-DNA interactions that are required to maintain the structure of DNA and to preserve the genetic
integrity of DNA. Our current research is focused in two general areas, DNA replication and DNA repair.
We are investigating the activities of individual enzymes required for these processes, as well as the
coordination and timing of interactions between proteins and between proteins and DNA. In addition to using
traditional biochemical and biophysical approaches to study these systems, we are using novel fluorescence
techniques for monitoring these dynamic processes in real time.
MICHAEL R. BUBB, M.D. (273-5346) - Cell motility is relevant to virtually all aspects
of human physiology and pathophysiology, functioning critically in carcinogenesis, cardiovascular disease,
neurodevelopment, and autoimmunity. Students in our laboratory will learn biophysical and cell biological
techniques used to characterize protein-protein and protein-drug interactions. Undergraduate research
projects may focus on marine natural products that perturb cell motility, with an emphasis on the
development of pharmacological agents that exploit the motile properties of cells to treat human
disease. Additional undergraduate projects concern the role of cell motility in memory and learning
or in the development of cancer.
JÖRG BUNGERT (392-0121) - Our laboratory is interested in fundamental mechanisms governing the
regulation of chromatin structure and gene expression in eukaryotic cells. As a model system, we study
the regulation of the human b-globin gene locus, which is active only in red blood cells. The five
human b-globin genes are located on chromosome 11 in an order reflecting their expression during development
with the embryonic e-globin gene at the 5’ end and the adult b-globin gene at the 3’ end.
Developmental stage-specific expression of the genes is mediated by DNA regulatory elements that are
located proximal and distal to the genes. One of the most prominent and powerful distal DNA regulatory
elements in the b-globin locus is the locus control region (LCR), located from 8 to 22 Kbp upstream of
the e-globin gene. The LCR is composed of several units that act together to confer high-level
globin gene expression. The LCR harbors both strong enhancer as well as chromatin opening activities.
We are using biochemical, molecular, and genetic methods to analyze LCR structure and function. In
the biochemical assays, we reconstitute the LCR in vitro and analyze protein-protein and protein-DNA
interactions. In the molecular studies we analyze the interaction of transcription complexes and other
transcription factors with the globin locus in erythroid cells using in vivo methods. In the genetic
studies, we generate transgenic mice with wild-type and mutant globin loci and analyze globin gene
expression and chromatin structure to dissect the function of regulatory elements. We also use genetic
methods, homologous and site specific recombination techniques, to develop novel procedures for the
site-specific integration of globin expression constructs into the mouse genome.
BRIAN D. CAIN (392-6473) - The proton-translocating ATP synthases are the principal energy-transducing
enzymes of most biological organisms. Both the mechanism of protein-facilitated proton movement across the
membrane and the processes coupling proton translocation to catalysis are unknown. We are interested
in studying these questions using a combination of biochemical and molecular biological approaches.
Analysis of site-directed mutations resulting in defective proton translocation allows for the assignment
of functional roles to specific amino acid residues in the enzyme.
NANCY D. DENSLOW (392-4700 x 5563) - My laboratory works on developing biomarkers
at the protein and mRNA level that relate to exposure to environmental contaminants. We use
fish as models because they are present in the environments that are most contaminated. We are
looking at compounds that behave as estrogen or androgen mimics and that turn on the expression
of genes controlled by these hormones at inappropriate times. We are interested in finding out
how these compounds adversely affect health and reproduction. We have developed both in vivo assays
and cell based assays to measure activity of estrogen receptors and use microarrays and proteomics
approaches to identify biomarkers that are relevant to mechanisms by which contaminants exert
their deleterious effects. A new direction in the laboratory is to examine the health effects
of exposure to nanoparticles.
BEN M. DUNN (392-3362) - Our laboratory is directed at understanding the interactions that lead
to enzyme specificity and catalysis, especially for proteolytic enzymes. In this way, we hope to discover
critical interactions contributing to binding and catalysis, and identify points important in selective drug
design. Included in the systems that are under study are several members of the aspartic proteinase class of
enzymes; the digestive enzymes pepsin and gastricsin, the tissue enzymes cathepsin D and E, and the virally
encoded enzyme from the Human Immunodeficiency Virus (HIV), the causative agent for AIDS, as well as other
retroviruses. We are also involved in another study dealing with similar enzymes from the malarial parasite,
Plasmodium falciparum. We also study some members of the serine proteinase family, such as bacterial
subtilisins and a related enzyme from human brain, CLN2, involved in a neurodegenerative condition,
classical late-infantile neuronal lipofuscinosis. We use molecular biology, microbiology, protein chemistry,
enzymology, x-ray diffraction, and molecular biophysics.
ARTHUR S. EDISON (392-4535) - My laboratory focuses on the structure-function relationships of small,
biologically active neuropeptides. Our primary tools are high-resolution NMR spectroscopy, molecular biology,
protein expression, and computer modeling. NMR: Structural studies of FMRFamide-like peptides (FLPs) and
other peptides. Students can learn NMR acquisition, data processing, and data analysis on several relatively
simple peptides. This work involves the same techniques that are used for complete proteins but on smaller
molecules. Molecular Biology: Identification of new FLP receptors. Students can find an invertebrate
(e.g., mollusk, nematode, arthropod, etc.), extract RNA, make cDNA, and use PCR to find new FLP receptors.
Isolate peptide antibody clones from a phage library. Students can screen a phage library for clones that
bind to particular FLP sequences. Once clones are identified, students can use bacterial mutagenesis to
optimize the binding of the antibody fragments. Other: Interested students can arrange to work on other
ongoing projects.
Email: art@ascaris.health.ufl.edu
SUSAN C. FROST (392-3207) - Glucose acts as both a metabolic substrate and a signaling molecule.
My laboratory is interested in both aspects of glucose function. As a signaling molecule, we believe that
glucose depresses its own flux into cells. This means that in its absence, the activity of the protein
that mediates its transport across the plasma membrane is substantially increased. We have hypothesized
that the increase in transport activity is related to the synthesis of a novel protein during glucose
deprivation. This protein may modulate the activity of the existing transporter....or function as a new
transport molecule, itself. We are currently using both biochemical and molecular techniques to identify
this protein. We are also interested in protein processing, and particularly that of the insulin receptor,
in response to glucose deprivation. Using antibodies to identify the receptor, we have shown that glucose
deprivation alters glycosylation of the receptor which prevents its release from the point of synthesis
(the endoplasmic reticulum). This is allowing us to model certain human disease states which cause retention
of the receptor in the endoplasmic reticulum, preventing its targeting to the plasma membrane which is its
functional domain.
SUMING HUANG (273-8199) - My research interests focus on epigenetic regulation of chromatin structure and
gene expression. We study the structure and function of chromatin insulator located at the 5’end of chicken b-globin
locus. We have identified two kinds of insulator functions mediated by distinct proteins and co-factors, one is CTCF
that blocks inappropriate activation of a promoter by a distal enhancer, and the other acts as a chromatin barrier
against encroachment of heterochromatin into adjacent euchromatin regions. The second activity relies on binding of
the transcription factors USF1/USF2 and its ability to recruit histone modifying enzymes. Currently, we are examining
the mechanisms of which USF1 maintains a local environment of active chromatin, both by biochemical and functional
analysis of the USF1 containing protein complexes, and by studies of the effects of protein knockdown on the local
and long range chromatin structure and histone modification patterns. Another project my laboratory will focus is
the regulation of TAL1 oncoprotein activity. Activation of the TAL1 gene is the most frequent gain-of-function
mutation in T-cell acute lymphoblastic leukemia (TALL). We will use biochemical and epigenetic approaches to determine:
1) The mechanism underlying the ectopic activation of TAL1 transcription, 2) The mechanism dictating the TAL1 activity
in normal and pathological hematopoiesis.
SHALESH KAUSHAL (contact Mark P. Krebs, 392-8561) - An exciting new concept in molecular medicine
is that many human diseases may be caused by defects in protein folding. To test this idea, our laboratory
studies misfolded proteins associated with inherited eye diseases, particularly retinitis pigmentosa (RP).
Many families with RP have mutations in rhodopsin, a protein in the eye that binds vitamin A and detects
light. We are actively exploring how misfolded rhodopsin causes RP and developing approaches to treat the
disease. In one approach, we add small molecules, such as vitamin A, that bind to the protein and improve
its folding in the cell. In another, we stimulate cellular pathways to remove the misfolded protein.
We seek talented and motivated students to help with this work. Students can expect to learn PCR, cloning,
sequencing, cell tissue culture, protein gel electrophoresis, and UV/visible spectroscopy.
WILLIAM R. KEM (392-0669) - My lab investigates naturally occurring toxins, their use as molecular
probes of membrane ion channel function and as molecular models for the design of new drugs. Three types
of toxins are currently under investigation:(1) heterocyclic compounds from nemertine worms that selectively
activate certain brain nicotinic acetylcholine receptors, are being used to design drugs which can enhance
cognition (learning and memory) in persons suffering from dementia, (2) peptide toxins which affect
voltage-gated sodium or potassium channels in lymphocytes and brain neuronal membranes are being used
as models for designing new immunosuppressant drugs, and (3) proteins which lyse cells by forming new
membrane ion channels are used to understand how proteins insert into membranes. In addition we are also
investigating the chemistry and molecular mechanisms of action of certain plant alkaloids, which block
nicotinic acetylcholine receptors in the brain. The lab offers the student opportunities for learning how
to purify and characterize peptides, proteins, and heterocyclic molecules, and for learning pharmacological
techniques, including radio ligand binding to receptors, 96-well functional assays using cultured cells,
isolated muscle and nerve preparations and whole animal assays. Computer modeling is used to visualize the
docking of these molecules with their receptors.
PHILIP J. LAIPIS (392-6870) - Mitochondrial DNA is a unique genetic entity. We are using DNA
cloning/sequencing and pedigree analysis of inbred animals to understand the mechanisms of maternal
inheritance of mitochondrial DNA. We are studying mitochondrial segregation after microinjection of
mitochondrial into oocytes with the long-term goal of developing a mitochondrial genetic exchange system.
A second focus of our research involves cloning the genes for mammalian carbonic anhydrase isozymes and
using site-directed mutagenesis to achieve an understanding of the differences in enzyme mechanisms.
We are also looking at how regulation of the tissue-specific expression of this gene family occurs.
JOANNA R. LONG (846-1506) - Our laboratory is studying the complex interactions between
proteins and cell membranes in order to understand the roles of specific lipids and cholesterol in
affecting protein structure, binding, and function. We are especially interested in two classes of proteins:
membrane-spanning signal transduction proteins and proteins involved in lipid trafficking and modification.
Our studies are currently focused on lung surfactant protein B, a protein critical to proper lung compression
and expansion; the ion channel-forming domain of the nicotinic acetylcholine receptor, a major target of
anesthetics and neurotoxins; the avb3 integrin receptor, a protein important to cell binding and
differentiation; and the amyloid b peptide, the causative agent in Alzheimer ‘s disease. We also are
examining the potential for immobilizing these proteins in a functional state on polymers and electronic
sensors for biomedical engineering applications. We use protein chemistry, molecular biology, calorimetry,
optical spectroscopy, and solid state NMR in our inquiries.
JIANRONG LU (273-8200) - The major research interest in the laboratory is toward understanding
the role of chromatin regulation in mammalian development and cancer. Defects in chromatin structure
lead to aberrant gene transcription and genetic instability, which contribute to many developmental defects
and cancers. Previously, we performed a genome-wide RNAi screen in cultured Drosophila cells and identified
chromatin factors implicated in repression of E2F, a transcription factor critical for cell proliferation and
differentiation. We are now extending this study using the mouse models. We focus on two types of chromatin
regulators: the mammalian SWR1 chromatin-remodeling complex and MBT domain-containing Polycomb Group (PcG)-like
proteins. Currently, we are using mouse genetics to address their function in embryonic development and tumor
suppression, and biochemical and molecular approaches to elucidate the mechanisms by which these factors modulate
chromatin and transcription.
PETER M. MCGUIRE (392-6853) - Our research interests focus on the regulation of gene expression
at the transcriptional level. Presently, recombinant human antibodies and phage display are being used
to isolate single chain antibody fragments [scFvs] which bind to molecules that regulate this process.
Expression of these antibody fragments in vivo has the potential to affect phenotype transiently and
thus provide insight into cell components and processes critical to normal development and homeostasis,
or to pathogenesis. Collaborations using these molecules include characterization of scFvs to hormones
and to tumor-specific cell antigens, for diagnostic and therapeutic evaluation, as well as development
of reagents to examine the cell surface components and genetics of the red tide organism Karenia brevis.
ROBERT McKENNA (392-5696) - My laboratory focuses on the structure-function relationships of
biological macromolecules. Our primary research techniques are X-ray crystallography and three dimensional
computer modeling and in collaboration with other research groups,
molecular biology, protein and virus expression. The goals of our research
is to understanding biological processes at the atomic structure level and identify how
the complex amino acid and/or nucleic acid structure of a biological macromolecule is utilized
to perform a specific function. We current study various enzymes and correlate their structure to function.
Interested students can arrange to work on ongoing or initiate new projects in collaboration with other
faculty.
JAN S. MOREB (392-9004) - My laboratory interest centers on the significance of aldehyde dehydrogenases
in the biology of lung cancer. Lung cancer is the leading cause of cancer-related mortality. In order to
impact the curability of lung cancer, we need to better understand the biology of the disease. Aldehyde
dehydrogenase class-1A1 (ALDH-1) and class-3A1 (ALDH-3) have been reported to be highly expressed in non-small
cell lung cancer. These enzymes are known to be responsible for drug resistance in many cancer types and be
involved in carcinogenesis and malignant transformation. Our main working hypothesis is that high levels of
these enzymes in lung cancer are related to the evolution of the malignant process and exposure to carcinogens,
and may reflect a malignant phenotype with drug resistance against a wide range of anticancer drugs.
Our specific aims are to establish the relationship between ALDH-1/ALDH-3 and the pathogenesis of lung
cancer, and to determine the relative contribution of each isozyme to drug resistance against
4-hydroperoxycyclophosphamide.
HARRY S. NICK (392-3303) - Our laboratory's research focuses on understanding how mammalian genes
are turned on and off by cell- and tissue- specific mechanisms. We utilize advanced techniques in molecular
biology to study molecular mechanisms which control how genes are regulated, by understanding the
organization of chromatin structure and studying protein-DNA interactions. We study specific genes
which are closely linked to the underlying mechanisms which influence tissue inflammation in the lung,
intestine, and brain. Studies are primarily concerned with gene regulation at the following loci: 1)
the manganese superoxide dismutases, which serve as intracellular antioxidant regulators; 2) the inducible
form of nitric oxide synthase which produces a potent vasodilator and neurotransmitter, nitric oxide; and 3)
the cytoplasmic phospholipase A2, an enzyme which generates metabolites involved in promoting inflammation
as well as intracellular signaling pathways. Our lab also pursues studies on gene expression following spinal
cord injury where we are studying the induction of genes following this type of insult. In addition we have
an active program in gene therapy targeting genes that protect cells from damage in models of spinal cord
injury and an extensive program in diabetes. There is an immediate opening in our lab for an undergraduate
student.
THOMAS W. O’BRIEN (392-6878) - Our studies have shown that mammalian mitochondria contain unusual
ribosomes that differ structurally and functionally from other ribosomes. These ribosomes are products
of two separate genomes, and they appear to be evolving more rapidly than other ribosomes. Among their
remarkable features is the presence of several new proteins not found in other ribosomes, including a GTP
binding protein implicated in programmed cell death. We are using affinity probes, immunologic, and
biochemical approaches to study their organization and unique functional properties. The nuclear genes
for all of the mitoribosomal proteins are scattered among different chromosomes, many mapping to disease
loci associated with deficiencies in energy metabolism, such as neuropathies, myopathies, developmental
and sensorineural disorders and deafness. Other studies address the mechanism of mRNA binding to mitochondrial
ribosomes, and the role of specific initiation factors and GTP in the initiation of protein synthesis in
this novel translation system.
DANIEL L. PURICH (392-9410) - Microtubules play central roles in cell motility, mitosis, and
specialization, and my primary research goal is to understand such processes at the molecular level.
Ultimately, every aspect of microtubule action (including self-assembly, coordination with other cellular
organelles, and effective regulation) will be related to the unique structural and chemical properties of
the microtubule proteins. We seek to identify and to characterize these molecular design properties by
borrowing, combining, and extending techniques in biophysics, enzymology, and cell biology with the further
intent to provide an integrated molecular and cellular perspective.
VIJAY S. REDDY, M.D. Ph.D. (392-7346) - Our research is based on cancer immunology focusing
on blood stem cell or bone marrow transplantation. We address complications of cancer patients after
transplantation and study the immune system in the laboratory to understand and develop new treatments
against cancer. Our studies include specialized immune cells called dendritic cells and lymphocytes and
inflammatory cytokines from human blood that may have a potential as vaccines to challenge patient's own
immune system to fight against cancer. The student will learn about laboratory bench to bedside
"translational" basic and clinical research and develop an understanding of the immune system and interaction
with cancer.
KEITH D. ROBERTSON (392-1810) - The focus of the laboratory is on understanding how epigenetic
modifications of the genome, such as DNA methylation and core histone post-translational modifications,
regulate normal cellular processes (development & differentiation) and how dysregulation of these
modifications leads to human disease. We are particularly interested in how aberrant DNA methylation
patterns in the genome contribute to cancer and how DNA methylation may be used a biomarker to detect
and diagnose cancer more effectively. Specifically, we use many molecular biology techniques (PCR, RT-PCR,
cell culture, recombinant DNA, and expression microarrays) to identify important growth regulatory genes
that undergo aberrant DNA methylation-mediated silencing in cancer and, if the gene function is not known,
we undertake a variety of assays to try and better understand its role in cancer formation and/or progression.
KATHLEEN T. SHIVERICK (392-3545) - Regulation of Reproductive Function and Fetal Growth - A major area
of investigation, funded by the Superfund Program Project Grant and NIH, is studying cultured human placental,
uterine and prostate cell lines to characterize the direct effects of cigarette smoke and prototype environment
al chemicals on the expression of growth regulatory genes. Our hypothesis is that carcinogens, polychlorinated
biphenyls and/or dioxins alter reproductive function by disrupting growth regulatory networks, which are
recognized to be essential for differentiation, proliferation, migration and hormone secretion. The growth
regulatory systems under study include the cell cycle regulatory proteins (cyclins and their inhibitors),
the tumor suppressor gene p53, and the major pro-inflammatory cytokines (ILs-1, -2, -8; TNF-a and interferon).
Dose-response relationships are being established for altered expression of specific genes to determine
which endpoints are the most sensitive biomarkers of exposure and toxicity. Studies are evaluating whether
these environmental chemicals alter gene expression at the level of transcription or mRNA stabilization,
as well as at the level of protein products. Gene expression profiling (genomics) and knockout experiments
are in progress to identify which cell signalling molecules and pathways mediate the major toxic effects on
cell functions. Thus, the dysregulation of cell cycle progression and cytokine gene expression may interfere
with normal placental growth and vascular development, which may predispose to low birth weight. Our studies
with a number of human uterine and prostate cancer cell lines have found selective deregulation of specific
genes important for migration and inflammatory responses. These studies will provide essential information
in determining whether environmental contaminants may be linked with uterine endometriosis or infertility
in women, as well as prostatic disease in men.
DAVID N. SILVERMAN (392-3556) - Our laboratory is involved in research on the basic steps of very
fast enzymes. Of particular interest is the large number of carbonic anhydrase isozymes that convert CO2
into HCO3- and a proton as well as the antioxidant enzyme superoxide dismutase; these are among nature’s
most rapid catalysts. Using site-directed mutagenesis, this research aims to understand the role of specific
amino acids in the rapid catalysis and to relate this information to a functional role for the enzymes in
cells. The methods used are mass spectrometry, nuclear magnetic resonance, rapid-mixing kinetics, and
computer modeling. Students will be able to use these instrumental methods as applied to problems in
enzyme catalysis and inhibition. The design and testing of drugs that inhibit these enzymes are also part
of this work.
W. CLAY SMITH (392-0476) - Research in my lab centers on the molecules involved in phototransduction -
the biochemical process by which photons are converted into a neural signal. The phototransduction enzyme
cascade is an exquisitely sensitive system, being capable of producing a neural response to a single photon.
Our fundamental approach is a combination of molecular biology coupled with biochemistry. Specifically, we
create directed mutants of the phototransduction elements and test the heterologously-expressed components in
functional assays. Interesting leads are ultimately tested in transgenic frogs to prove that what we find in
the test tube is how it really works in the animal. Students in my lab can expect to learn molecular biology
techniques (pcr, cloning, DNA sequencing, etc.), protein chromatography, and confocal microscopy.
PETER W. STACPOOLE (392-2321) - Our work centers on the causes and treatment of genetic and acquired
disorders of mitochondrial energetics. In particular, we are interested in understanding the molecular,
biochemical, and clinical consequences of congenital mutations in nuclear or mitochondrial DNA that give rise
to loss of function of critical mitochondrial enzymes involved in substrate utilization and oxidative
phosphorylation. We use predominantly human biopsy tissue to investigate the cellular and molecular
pathobiology of these diseases and employ recombinant adeno-associated virus technology to develop novel
approaches for gene therapy. We have developed investigational drugs for the treatment of inborn errors
of mitochondrial energy metabolism and utilize magnetic resonance spectroscopy to elucidate the
intra-mitochondrial biochemical consequences of discrete mutations.
MARGARET (PEGGY) WALLACE (392-3055) - Our laboratory studies mammalian molecular genetics,
including projects to map and clone disease genes, and to find and study mutations. The human genetic
disorders currently include neurofibromatosis (tumor syndrome), heart defects, dog hereditary eye conditions,
and genetics of pain. Most students will have an independent sub-project to answer a particular question, or
will generate data as an integral part of a larger effort. This will involve learning molecular biology
techniques such as DNA extraction, PCR, restriction digests, gel electrophoresis, genotyping markers, and
possibly some RNA or cell culture/biology work. We prefer students who can be a member of the lab for at
least a full calendar year.
THOMAS P. YANG (392-6472) - Our laboratory is interested in two general areas of research: the molecular
biology and genetics of the mammalian X chromosome, and transcriptional regulation of gene expression in
higher eukaryotes. Three major projects in these areas are currently underway in the laboratory. We are
studying the mechanism of mammalian X chromosome inactivation, a process that equalizes the functional
dosage of X-linked genes between males and females. Because each female somatic cell carries two X
chromosomes while male cells contain only one, each female somatic cell transcriptionally inactivates
genes on one of the two X chromosomes. We are studying the molecular mechanisms by which this novel
system of differential gene expression is initiated and maintained in female cells. We are also engaged
in studies on the molecular mechanisms of genomic imprinting in mammals, the process by which certain
mammalian genes are transcribed in a parent-specific manner. Some imprinted genes are expressed only from
the chromosome that comes from the mother, and other imprinted genes are expressed only from the chromosome
inherited from the father. Our studies are focused on the regulation of imprinted genes in the
Prader-Willi/Angelman syndrome region of human chromosome 15. For the third project, we are using the
techniques of molecular genetics to localize and map disease genes associated with two X-linked human
diseases, a unique from of X-linked arthrogryposis (congenital joint contractures), and an uncharacterized
X-linked mental retardation and seizure disorder.
FAQ | Forms | Add. Info. | Links | Contacts | Home |
| | ||||||||